[1] Li BS, Wang H, Gonen O. Metabolite ratios to assumed stable creatine level may confound the quantification of proton brain MR spectroscopy[J]. Magn Reson Imaging, 2003, 21(8):923-928.
[2] Vermathen P, Capizzano AA, Maudsley AA. Administration and 1H MRS detection of histidine in human brain:application to in vivo pH measurement[J]. Magn Reson Med, 2000, 43(5):665-675.
[3] Tong Z, Yamaki T, Harada K, et al. In vivo quantification of the metabolites in normal brain and brain tumors by proton MR spectroscopy using water as an internal standard[J]. Magn Reson Imaging,2004, 22(7):1017-1024.
[4] Silverstone PH, Donnell T, Ulrich M, et al. Dextro-amphetamine increases phosphoinositol cycle activity in volunteers:an MRS study[J]. Hum Psychopharmacol, 2002,17(7):321-327.
[5] Wu RH, Donnell T, Ulrich M, et al. Brain choline concentrations may not be altered in euthymic bipolar disorder patients chronically treated with either lithium or sodium valporate[J]. Ann Gen Hosp Psychiatry, 2004, 3(1):13.
[6] Shen J, Douglas L, Rothman, et al. In vivo GABA editing using a novel doubly selective multiple quantum filter[J]. Magn Reson Med,2002, 47(3):447-454.
[7] Donnell T, Rotzinger S, Nakashima TT, et al. Chronic lithium and sodium valproate both decrease the concentration of myo-inositol and increase the concentration of inositol monophosphates in rat brain[J]. Eur Neuropsychopharmacol, 2003, 13(3):199-207.
[8] Sager TN, Laursen H, Fink-Jensen A, et al. N-acetylaspartate distribution in rat brain striatum during acute brain ischemia[J]. J Cereb Blood Flow Metab, 1999, 19(2):164-172.
[9] Wu RH, Silverstone P, Rao HB, et al. Quantitative measurement of brain metabolite concentrations using PRESS sequence at 3T[J].Radiology, 2002, 225(p):667.
[10] Kimura T, Sako K, Gotoh T, et al. In vivo single-voxel proton MR spectroscopy in brain lesion with ring-like enhancement[J]. NMR Biomed, 2001, 14(6):339-349.
[11] Simister RJ, Mclean MA, Barker GJ, et al. Proton MRS reveals frontal lobe metabolite abnormalities in idiopathic generalized epilepsy[J]. Neurology, 2003, 61(7):897-902.
[12] Seeger U, Klose U, Mader I, et al. Parameterized evaluation of macromolecules and lipids in proton MR spectroscopy of brain diseases[J]. Magn Reson Med, 2003, 49(1):19-28.
[13] Mclean MA, Woermann FG, Barker GJ, et al. Quantitative analysis of short echo time 1H-MRSI of cerebral gray and white matter[J].Magn Reson Med, 2000, 44(3):401-411.
[14] Hajek M, Burian M, Dezortova M. Application of LC-model for quality control and quantitative in vivo 1H-MR spectroscopy by short echo time STEAM sequence[J]. Magn Reson Materials Phy Bio 1 Med,2000, 10(1):6-17.
[15] Mclean MA, Busza AL, Wald LL, et al. In Vivo GABA+ Measurement at 1.5T using a PRESS-localized double quantum filter[J].Magn Reson Med, 2002, 48(2):233-241.
[16] Tyson RL, Gallagher C, Sutherland GR. 13C-labeled substrates and the cerebral metabolic compartmentalization of acetate and lactate[J]. Brain Res, 2003, 992(1):43-52.
[17] Gruetter R, Seaquist ER, Kim SG, et al. Localized in vivo 13C-NMR of glutamate metabolism in the human brain:initial results at 4 tesla[J]. Dev Neurosci, 1998, 20(4-5):380-388.